Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Dongjak-Gu, Korea, Republic of Clinical Trials

A listing of Dongjak-Gu, Korea, Republic of clinical trials actively recruiting patients volunteers.

RESULTS

Found (70) clinical trials

An Extension Study of PEAK Trial

PEAK trial is now undergoing (Multicenter, randomized, double blind, three-arm parallel group study to evaluate efficacy and safety of Alogliptin and Pioglitazone combination therapy on glucose control in type 2 diabetes subjects who have inadequate control with Metformin monotherapy in Korea, Takeda No. ALO-IIT-012). Duration of combination treatment is 24 ...

Phase

0.45 miles

Learn More »

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will ...

Phase

1.92 miles

Learn More »

Manidipine Versus Amlodipine in Patients With Hypertension

Dihydropyridine Calcium Channel Blockers (CCBs) are one of the most commonly used potent antihypertensive agents. Their vasodilatory effects are associated with Adverse Effects (AEs) such as peripheral edema, headache and flushing. The incidence of peripheral edema with Calcium Channel Blocker (CCB) is 6% in a recent systematic review and is ...

Phase

1.92 miles

Learn More »

S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension

The aim of this study is to verify the difference at week 12 from the baseline value in the average variation of diastolic blood pressure (sitDBP) of the study group in which S-amlodipine / Chlorthalidone combination therapy is to be used in patients with essential hypertension who did not adequately ...

Phase

1.92 miles

Learn More »

Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan

To evaluate the efficacy and safety of amlodipine besylate and candesartan cilexetil administered in a fixed-dose combination tablet versus co-administered as their separate formulations in patients with essential hypertension who have shown inadequate response on monotherapy of amlodipine or candesartan cilexetil or who are with blood pressure adequately controlled by ...

Phase

4.3 miles

Learn More »

A Long-term Extension Study of Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension.

To provide riociguat therapy to eligible patients with PAH originating from Bayer-sponsored trials with BAY63-2521/ Riociguat / Adempas who are currently or recently treated in these trials until lack of patient benefit as assessed by investigator, or commercial availability and reimbursement.

Phase

4.3 miles

Learn More »

Study to Compare the Efficacy and Safety of CELBESTA and CELEBREX in Patients With Rheumatoid Arthritis

Thisi is a multi-center, double-blind, active-controlled, randomized, parallel-group clinical trial to compare the efficacy and safety of CELBESTA and CELEBREX in patients with rheumatoid arthritis. The subject will receive two tablets twice daily for 6 weeks.

Phase

4.3 miles

Learn More »

Study on Treatment of Pegylated Interferon Alfa 2a(Pegasys ) in the Korean Chronic Hepatitis B(CHB) Adults

Patients will receive Peginterferon alfa-2a according to the standard medical practice but the observation period is 12 weeks

Phase

4.3 miles

Learn More »

Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI

With the development of the newer generation drug-eluting stents, percutaneous coronary intervention (PCI) has been a feasible treatment for patient with coronary artery disease. However, stent failures including in-stent restenosis and stent thrombosis have been still problematic. Moreover, neoatherosclerosis, which is the atherosclerotic process developed in the neointima within the ...

Phase

4.3 miles

Learn More »

Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy

Data from a previous single arm study (RESPITE) indicate that transition from PDE5i to riociguat may be feasible, safe and beneficial in patients not adequately responding to PDE5i. REPLACE is a randomized controlled study to confirm the potential clinical benefit of transition from PDE5i to riociguat. Satisfactory clinical response in ...

Phase

4.3 miles

Learn More »